Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
Shaffer CL, Dutra JK, Tseng WC, Weber ML, Bogart LJ, Hales K, Pang J, Volfson D, Am Ende CW, Green ME, Buhl DL.
Shaffer CL, et al. Among authors: volfson d.
Neuropharmacology. 2019 Jul 15;153:73-81. doi: 10.1016/j.neuropharm.2019.04.019. Epub 2019 Apr 20.
Neuropharmacology. 2019.
PMID: 31015046